London
3 °C
Manchester
4 °C
Glasgow
Dublin
6 °C
Belfast
Washington
Denver
11 °C
Atlanta
Dallas
Houston Texas
21 °C
New Orleans
El Paso
Phoenix
Los Angeles
14 °C
-13 °C
24 °C
22 °C
Featured
Last news
Pakistan tightens Islamabad security after suicide blast
Residents in the Pakistani capital Islamabad were facing tightened security checks on Wednesday in the wake of a suicide bombing that left top officials vowing to halt the rise in deadly attacks.
Corruption scandal, court battles pose test for Zelensky
A major corruption scandal and mounting accusations that the Ukrainian presidency is using the judiciary to intimidate and silence critics has rocked Kyiv, presenting a significant test for Volodymyr Zelensky almost four years into the Russian invasion.
DR Congo ex-rebel leader Lumbala's war crimes trial opens in Paris
Former Congolese rebel leader Roger Lumbala goes on trial in Paris Wednesday over atrocities committed in the Democratic Republic of Congo's bloody eastern conflict more than two decades ago.
Cambodia's Prince Group denies link to scams after asset seizures
A Cambodian conglomerate whose founder has had more than $15 billion of allegedly ill-gotten assets seized said it "categorically rejects" claims he amassed his fortune running an internet scam empire.
Ousted Gabon leader's wife and son sentenced to 20 years for graft
A Gabon court on Wednesday sentenced the former first lady and son of the oil-rich country's deposed leader Ali Bongo to 20 years in prison following a two-day graft trial.
Bangladesh's liquor industry a surprising success
Syrupy aromas drift across the guarded compound of Bangladesh's only licensed distillery, a state-owned producer posting record profits in the Muslim-majority nation, where Islamists are staging a political comeback.
NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close
SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced the closing of its previously announced securities purchase agreement with a single healthcare institutional investor for the purchase and sale of 3,571,429 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.68 per share in a registered direct offering (the "Offering"). The gross proceeds from the Offering are approximately $6 million, before deducting placement agent commissions and other offering expenses. In addition, in a concurrent private placement, the Company has issued and sold Series A warrants to purchase up to 3,571,429 shares of common stock (the "Series A Warrants") and Series B warrants to purchase up to 3,571,429 shares of common stock (the "Series B Warrants" and, together with the Series A Warrants, the "Warrants"). The Series A Warrants have an exercise price of $1.75 per share, are exercisable after 6 months from date of issuance, and expire 2 years following the issuance date. The Series B Warrants have an exercise price of $2.00 per share, are exercisable after 6 months from date of issuance, and expire 5.5 years following the issuance date. The exercise price of the Series B Warrants represents approximately a 20% premium to the closing price for the Company's common stock on November 10, 2025.
Arrival of US aircraft carrier fuels Venezuelan fears of attack
A US aircraft carrier strike group arrived in Latin America Tuesday, escalating a military buildup Venezuela has warned could trigger a full-blown conflict as it announced its own "massive" deployment.
Turkey seeks more than 2,000 years behind bars for Erdogan rival
Turkish prosecutors on Tuesday charged Istanbul's jailed mayor Ekrem Imamoglu with 142 offences in a massive legal case that could carry a penalty of more than 2,000 years in jail, court documents showed.
Prosecutor files 142 charges against Istanbul mayor, a top Erdogan critic
Turkish prosecutors on Tuesday charged Istanbul's jailed mayor Ekrem Imamoglu with 142 offences that could carry a penalty of hundreds of years in prison, court documents showed.
Pakistani Taliban claim deadly suicide attack in Islamabad
The Pakistani Taliban claimed a suicide bombing that killed at least 12 people in Islamabad on Tuesday, a rare attack by the militant group on the country's capital.
Suicide bombing in Islamabad kills 12, wounds 27
A suicide bombing outside district court buildings in the Pakistani capital Islamabad killed at least 12 people and wounded 27 on Tuesday, the interior minister said.
Indian PM calls deadly Delhi blast 'conspiracy'
Indian Prime Minister Narendra Modi on Tuesday called a deadly car explosion in the heart of the capital that killed at least eight people a "conspiracy", vowing those responsible will face justice.
India probes deadly Delhi blast, vows those responsible will face justice
India's defence minister vowed on Tuesday that those responsible for a deadly car explosion in the heart of the capital that killed at least eight people will face justice.
Philippines digs out from Typhoon Fung-wong as death toll climbs to 18
Rescuers using backhoes and chainsaws began digging the Philippines out from the devastation of Typhoon Fung-wong on Tuesday, as floodwaters receded in hundreds of villages and the storm's death toll climbed to 18.
Sony hikes profit forecasts on strong gaming, anime sales
Japanese giant Sony hiked its full-year revenue and profit forecasts Tuesday on the back of the huge global success of the latest "Demon Slayer" anime blockbuster.
Indian forensic teams scour deadly Delhi car explosion
Indian crime scene investigators scoured through the wreckage of a car on Tuesday that exploded hours earlier in the heart of the capital, killing at least eight people.
Climate Goals Threatened by Industrialised Animal Farming, Reveals Key International Study
LONDON, UK / ACCESS Newswire / November 11, 2025 / A new study in Animals highlights that industrialized animal farming is one of the most powerful - yet persistently neglected - forces driving the climate and biodiversity crises. The analysis, "The Missing Target: Why Industrialized Animal Farming Must Be at the Core of the Climate Agenda," synthesizes evidence from 47 international studies and concludes that reducing livestock production and embracing plant-based food systems is essential for meeting global climate goals.
Dogwood Announces Enrollment of First 100 Patients in Ongoing Halneuron(R) Phase 2b Trial, Interim Sample Size Analysis on Track for December 2025
- Continued low early termination rate among the first 80 study completers suggests Halneuron® and placebotreatmenthave been well tolerated
NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close
SHELTON, CONNECTICUT / ACCESS Newswire / November 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced that it has entered into a securities purchase agreement with a single healthcare institutional investor for the purchase and sale of 3,571,429 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.68 per share in a registered direct offering (the "Offering"). The gross proceeds from the Offering are expected to be approximately $6 million, before deducting placement agent commissions and other offering expenses. In addition, in a concurrent private placement, the Company will issue and sell Series A warrants to purchase up to 3,571,429 shares of common stock (the "Series A Warrants") and Series B warrants to purchase up to 3,571,429 shares of common stock (the "Series B Warrants" and, together with the Series A Warrants, the "Warrants"). The Series A Warrants will have an exercise price of $1.75 per share, will be exercisable after 6 months from date of issuance, and will expire 2 years following the issuance date. The Series B Warrants will have an exercise price of $2.00 per share, will be exercisable after 6 months from date of issuance, and will expire 5.5 years following the issuance date. The exercise price of the Series B Warrants represents approximately a 20% premium to the closing price for the Company's common stock on November 10, 2025. The closing of the Offering is expected to occur on or about November 12, 2025, subject to the satisfaction of customary closing conditions.
AI/ML Innovations Inc. Announces Grant of U.S. Patent Protecting Core ECG Signal-Processing Architecture
Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield™ and CardioYield™.Reinforces competitive advantage as the Company advances commercialization and regulatory pathways.
Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
November session to provide strategic context for Zomedica's product platforms featured in the previous Fourth Friday at Four Webinars
'Netflix House' marks streaming giant's first theme park
After years of temporary pop-up events, streaming giant Netflix will make its first foray into the theme park space this week, rivalling entertainment giants Disney and Universal Studios.
Top US court hears case of Rastafarian whose hair was cut in prison
The US Supreme Court on Monday heard the case of a devout Rastafarian who is seeking damages after his knee-length dreadlocks were forcibly shorn while he was in prison in Louisiana.
Chinese 'goddess of wealth' faces jail after huge UK crypto seizure
A Chinese woman facing a long jail term for her role in a multibillion-dollar Bitcoin scam lived in luxury as she evaded the authorities for years, a UK court heard Monday.
Indian capital car blast kills at least eight
A car explosion in the bustling heart of the Indian capital on Monday killed at least eight people and injured another 19, officials said.
US strikes on alleged drug boats kill six more people
US forces have killed six more people in strikes on alleged drug-running boats, Defense Secretary Pete Hegseth said Monday, bringing the campaign's total number of deaths -- which critics describe as illegal executions -- to 76.
Sarkozy released from jail 'nightmare' pending appeal trial
Nicolas Sarkozy on Monday was freed from prison, a 20-day experience the former president called a "nightmare", as a judge ordered his release pending an appeal decision over Libyan funding.
Typhoon Fung-wong floods Philippine towns, leaves 5 dead in its wake
Entire villages lay submerged and scores of towns remained without electricity on Monday as Typhoon Fung-wong left the Philippines after killing at least five people and displacing more than a million.
France's Sarkozy says prison a 'nightmare' as prosecutors seek his release
Nicolas Sarkozy on Monday called his imprisonment a "nightmare" as prosecutors requested the former French president be released from jail pending an appeals trial over Libyan funding.
Guinness maker Diageo picks new CEO after US tariffs cloud
Diageo, the maker of Guinness beer and Smirnoff vodka, announced Monday a new chief executive as it seeks to improve performance hit partly by US President Donald Trump's tariffs.
French court to decide if ex-president Sarkozy can leave jail
A French court is expected to decide on Monday whether to release ex-president Nicolas Sarkozy from jail pending an appeals trial over allegations that he sought Libyan funding.